Search Tag: Hologic

IMAGING Management

2021 08 Sep

Breast cancer is the most commonly diagnosed cancer in women, accounting for one in four annual cancer cases world wide 1  In Europe alone, 576,337 women were diagnosed with the disease in the year 2020 2  Breast cancer can have devastating effects on patients and the people around them, as the disease kills more European women than any other cancer.... Read more

IMAGING Management

2021 27 May

Thanks to early detection through routine breast screening as well as effective and efficient treatment, breast cancer patient survival rates have been increasing since 1989, especially for women under 50. 1  However, today Breast cancer is the most commonly diagnosed cancer in women, accounting for one in four annual cancer cases worldwide and kills... Read more

IMAGING Management

Hologic Receives Gallup Exceptional Workplace Award

2021 22 Mar

Hologic, Inc. , a global leader in women's health, has been named a winner of the 2021 Gallup Exceptional Workplace Award, the Company announced today. This prestigious award recognizes the most engaged workplace cultures in the world. Hologic has been on a six-year journey to create a culture of high engagement by focusing on developing talent,... Read more

IMAGING Management

3DQuorum™ Imaging Technology

2021 25 Feb

Improving radiologist performance through Artificial Intelligence and SmartSlices Brad Keller, Ph.D, Director, Clinical Research Breast Health, Hologic, Inc. Ashwini Kshirsagar, Ph.D, Chief Scientist, Clinical Solutions, Research and Development, Hologic, Inc. Andrew Smith, Ph.D., Vice President, Image Research Breast Health, Hologic. Inc.... Read more

IMAGING Management

Genius AI™ Detection for Breast Tomosynthesis

2021 24 Feb

Improving radiologist performance and workflow through deep learning AI applications. Ashwini Kshirsagar, Ph.D., Chief Scientist, Clinical Solutions, Research and Development, Hologic, Inc. Brad Keller, Ph.D., Director, Clinical and Scientific Affairs Breast Health, Hologic, Inc. Andrew Smith, Ph.D., Vice President, Image Research Breast Health,... Read more

IMAGING Management

Exceptional Image Quality Is Possible In O R With Faxitron Trident HD Specimen Radiography System

2021 11 Feb

At Hologic , we understand that there is nothing more important for your breast surgery patients than being sure.   Are the margins clear? Do you have the specimen of interest? Have the markers been captured? We also understand the need to minimise time under anaesthesia and recall rates for additional excisions, together with... Read more

IMAGING Management

Break Through Your Workflow Barriers With 3DQuorum™.  Our Highest Resolution 3D™ Imaging, Faster

2020 30 Oct

At Hologic , we understand the importance of reducing imaging interpretation time, especially during a time when you might be facing with a backlog in breast cancer screening appointments. We are therefore very pleased to introduce 3DQuorum breast imaging technology. Designed to expedite Hologic Clarity™ HD high-resolution 3D... Read more

IMAGING Management

Accelerate Detection With The 3DQuorum™, The Ultimate Breast Tomosynthesis Technology

2020 30 Oct

Hologic is pleased to introduce  3DQuorum Imaging Technology  to the Breast Health Continuum of Care. Designed to provide radiologists with fewer, thicker tomosynthesis slices to review, 3DQuorum uses Genius AI™- powered analytics to reconstruct high-resolution 3D mammography data to produce 6mm SmartSlices, with 70-micron pixel resolution.... Read more

IMAGING Management

Hologic Launches 3DQuorum™ Imaging Technology, Powered by Genius AI™, in Europe

2020 26 Oct

Innovation can help address screening backlog due to COVID-19 pandemic by streamlining breast imaging reading process Hologic, Inc  today announced the commercial availability in Europe of its 3DQuorum™ Imaging Technology, Powered by Genius AI™. The innovation was designed to help improve mammography efficiency and workflow, which is critical as... Read more

IMAGING Management

FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay

2020 06 Oct

Hologic, Inc.  announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in May, is now authorized for testing of individuals without symptoms or other reasons to suspect COVID-19 infection. This authorization follows an  announcement  last week... Read more